+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Industry Trends Analysis Report By Indication, By Product, By Phase, By Regional Outlook and Forecast, 2022-2028 - Product Thumbnail Image

Global Advanced Therapy Medicinal Products CDMO Market Size, Share & Industry Trends Analysis Report By Indication, By Product, By Phase, By Regional Outlook and Forecast, 2022-2028

  • Report
  • January 2023
  • 282 Pages
  • Global
From
Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application Outlook 2024 - Product Thumbnail Image

Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application Outlook 2024

  • Report
  • October 2019
  • Global
From
Lysosomal Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Lysosomal Disease Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Multiple sclerosis - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple sclerosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Niemann-Pick Type C Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Niemann-Pick Type C Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Extractables and Leachables Testing Services Market, 2018-2028 - Product Thumbnail Image

Extractables and Leachables Testing Services Market, 2018-2028

  • Report
  • September 2018
  • 200 Pages
  • Global
From
Charcot Marie Tooth Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Charcot Marie Tooth Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
State of the Biopharmaceutical Industry 2023 - Product Thumbnail Image

State of the Biopharmaceutical Industry 2023

  • Report
  • December 2022
  • 110 Pages
  • Global
From
RNA Targeting Small Molecule Drug Discovery Global Market Report 2024 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Precision and Personalized Medicine in Pharma - Thematic Intelligence - Product Thumbnail Image

Precision and Personalized Medicine in Pharma - Thematic Intelligence

  • Report
  • June 2023
  • 62 Pages
  • Global
From
Global Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Regional Outlook and Forecast, 2022-2028 - Product Thumbnail Image

Global Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Regional Outlook and Forecast, 2022-2028

  • Report
  • April 2022
  • 153 Pages
  • Global
From
Angelman Syndrome - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Angelman Syndrome - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Europe Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Europe Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022-2028

  • Report
  • April 2022
  • 70 Pages
  • Europe
From
North America Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

North America Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022-2028

  • Report
  • April 2022
  • 64 Pages
  • North America
From
Asia Pacific Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Asia Pacific Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022-2028

  • Report
  • April 2022
  • 70 Pages
  • Asia Pacific
From
LAMEA Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

LAMEA Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Country and Growth Forecast, 2022-2028

  • Report
  • April 2022
  • 70 Pages
  • Middle East, Africa
From
Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines - Product Thumbnail Image

Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines

  • Report
  • May 2021
  • 62 Pages
  • Global
From
Duchenne Muscular Dystrophy - Opportunity Assessment and Forecast to 2030 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Opportunity Assessment and Forecast to 2030

  • Report
  • December 2021
  • 83 Pages
  • Global
From
Pompe Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Pompe Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 104 Pages
  • Global
From
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2020 - Product Thumbnail Image

Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 164 Pages
  • Global
From
Loading Indicator